← Leaderboards
Martin C Woodle
Aparna Biosciences Corporation
$1,070,000
Attributed
$1,070,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $535K · FY2008–09$1M$750K$500K$250K$0
'08
'09
Funding mix
By agency
NIH$1,070,000 · 2
By mechanism
R43$1,070,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsNanoparticleIn VivoSmall Hairpin RnaTumorBaseGene FunctionIn VitroNucleic AcidsProteinsStructure-Activity RelationshipTissuesStructurePolypeptideAnimal ModelFoundationsGenesInterestReporterBiomedical ResearchBiologicalAnimal Disease ModelsBiochemistryCell Membrane
Grant awards (4)
Hybrid synthetic targeted lenti-VLP nanoparticle for gene delivery$299,600
R43 · FY2009 · CA · contact PI
In vivo RNAi nanoparticle cancer gene function reagent$235,400
R43 · FY2009 · CA · contact PI
Hybrid synthetic targeted lenti-VLP nanoparticle for gene delivery$299,600
R43 · FY2008 · CA · contact PI
In vivo RNAi nanoparticle cancer gene function reagent$235,400
R43 · FY2008 · CA · contact PI